-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PiVX9A3gIL9THcESewlN1AvmcFCLsF/z2mQq1psTi6wtpO4umvqh20gtwIAoVeMN X8TvywikRFb8RoC892tQQQ== 0000000000-09-004370.txt : 20090612 0000000000-09-004370.hdr.sgml : 20090612 20090128152329 ACCESSION NUMBER: 0000000000-09-004370 CONFORMED SUBMISSION TYPE: UPLOAD PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20090128 FILED FOR: COMPANY DATA: COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000899866 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133648318 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: UPLOAD BUSINESS ADDRESS: STREET 1: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06511 BUSINESS PHONE: 2037761790 MAIL ADDRESS: STREET 1: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06511 PUBLIC REFERENCE ACCESSION NUMBER: 0001193125-08-043592 LETTER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C0-)>+CS],-"C$Q(#`@;V)J#3P\+TQI;F5AF4@,C(O4')E=B`Q,#0V.2]2;V]T(#$R(#`@4B]);F9O(#$P(#`@4B]) M1%L\03%&,C$V0D$Q1C,W-$,S1CE#1#`X,3`X,T8T,S4U,40^/#-"-C@V-40V M,S(W,$)"-$5"0C!&1D4V-38P03,Q,D$P/ET^/@T*-`F@.(.<&J?1FXV1I\;G0E,$9[&ZSA.``69&-@D(@"TDQ`;`4VDD'=%$@# MS6'X#!!@``-[#8D-"F5N9'-T%LP(#`@-C$R M(#%LP(#`@-C$R(#7!E+U!A M9V4^/@UE;F1O8FH-,30@,"!O8FH-/#PO1F]N=#P\+U14,B`Q-2`P(%(O5%0T M(#$Y(#`@4CX^+U!R;V-3971;+U!$1B]497AT72]%>'1'4W1A=&4\/"]'4S$@ M,3<@,"!2/CX^/@UE;F1O8FH-,34@,"!O8FH-/#PO4W5B='EP92]47!E+T9O;G0^/@UE;F1O8FH-,38@,"!O8FH-/#PO M4W1E;58@.#(O1F]N=$YA;64O5&EM97-.97=2;VUA;E!3350O1F]N=%-T%LM-38X("TS,#<@,C`P,"`Q,#`W72]!7!E+T9O;G1$97-C'1'4W1A=&4O4T$@9F%L*>;-C>-.DFGCUIIF.ID^0")DHJ8)!2"MZ.^[ M"_`B2DKKC!U()';/GCU[@#>_/(;P9!8_KQ=OUNL(0ECO%F$$`?[#_XH`\F#E M%QFL7Q8!/.'O>DM_#@L&WOH?7"Y#/TQA?==_L?[IVN)7+FMX;-4>LB`,AJ\C M/T\I'H/QAYY$^134#X(@IG>6N(I6-O%'WG1<'R%:W4`4!(7=M#S==8X2!*M,!#?BJZ56UX;+_%7[,;S,P8?FJT_!J+]L07&XC2"3XUJ6\QSI^6K M.*T^&I/U5;RKA*FD%C?PSLO]B*FF$5O,U;409`FUB3+$/Z85%9,XQ3@99$/' M+E+](=X",F-;\;)!%N+0:B2?L36@<@$#=B]KW'37;C.T8T/P^HGD06JJRQ_,H]FT/)CB+-U,WK2Y1?=ZV:H.H4G8MP'*4 M-[]/:V2E(7)[?7$83'G-^M3W^XU3FUREG(2P1PJ_*9\P+#X M39YF[O5E?&X/D\FX)B>#9,89"VRWV1TUE.;S4>(XOK6;X_^=\%%XH7WT14#% M<0JT>)7B@"4=5:?QD]FKQ@BA1>[JQ!#4UIVJ:W60S1-L MU0N-9\A$TQH?X(M7X(?*\V.&ZDMQ4+6S$M$3$1:4P%8\^MIH1V'?-]F4.`NM M*&_@@!.94RS\B[EE\TS8P52JJTNLP$8-8S^.TPGVQ=B]2JS2UERJ;8>("2_( M9J*@5509+EQ%0ST?=@-NEV+FQQ/N7K&$K)2&/VF!9G(0<)!UC1'1"5/6D#MJ M0F$_:A#?]S5O>$LFX,HH_.2TC#,I?&7HSXCS4!V!2NFYCUPM!LOA^WV-Q&VL M\Z(2E9Y83\[13Q)Q0N-6'8;08+"./%`8@^<+TO!0"X[<;%`J!DK1.JWD?I+U M<&T"F@,]BJMD*DZ%SHFB@V)VO7':.&#*'- M4&"&C;"GR\1OD9ZYM3N*.O0^;5H:,2=`:;:U,IT6R,'MCF*XJ:1Q:BM++%XT MPA.<_9EH6XSX^DH)V97*-2>M\[*4]`*>MSU"%_.:;PPT^A?7E?^TY5X3)_6U M%6^M/^P[O5?XK.]3/Z51X*?Q5%4X!G:W&>*`FD6J(05BZ[@QTK2VD8.&W!7' M1IHI9D71OE(MR$;&]AZ244N\<@C768*%X^&E]GLW(RN:D:D?3B/8^]4$\N*F MA,5\Z_"N0&EBZQ+6/5ME=Z-`BEG?3F\U#`0Z."$B,.I5:([NX`I*_"*_4M#I MJ3\`M<"U0$;LRM&RDS7JIS?@S,Y)PJ!6ZIG.X@/7(\1PCO&RO0>EGTF+EK8C M>5?,+/_DCWCWP@/8VB9>D0;'=X-9L$EKF.*Z50X\'D3M>H4D(H-'^-8)0XHU MMMWN";>V?W1G%]\HO)!AL<,L1S]V?#9Z`WD@A5>('E<6]J!+9S\VT*7[G(RP MFT^L]5Z(&G9H[B3.+74/C<-.+&X/)R<J$=!TSD3P$F2@1FVC M5;IR(C\KKLU&X;S9!1*H-,2.QR#NMO[C0R^@V%_]^%+P?KWX5X`!`)P/8&<* M#0IE;F1S=')E86T-96YD;V)J#3$Y(#`@;V)J#3P\+U-U8G1Y<&4O5')U951Y M<&4O1F]N=$1E%LP(#`@-C$R(#'1=+T5X=$=3=&%T93P\ M+T=3,2`Q-R`P(%(^/CX^#65N9&]B:@TS(#`@;V)J#3P\+TQE;F=T:"`Q-S'YW8R22=3#V)VA>G#S`%26AH4@%)Q^IG](N[NP`ODJ6T4WO&@@!B<7;W MG,72K]]_"=FV7;Q9+5ZO5H*%;+59A`$/!`O@UXZ*@&5QRG/!5H^+@&T72QX$ M\&1)@RAAJQ^+>^^3\9<1CSS.?L=![&D_A+_?_&7L27\)*RW[HNN=9/X?JX]@ M9QGR,"XRMKHA.T$T6(R%M7A=J6?=U.QN)_T43,$!@J?>HRQ5W^E25NT5\Y>I M]Z$N^9'1B(PBR&*PF<;6YD=9^S$OO-[')SUI#O25B9P^KY@(:!`49V"BQ1PM MWGMW\U=_SN/M@DV13O., MQSE&^B@F.*(HRQI.?O1S`*_@V,*KN[];=J/;LF];C):LU^RZEM6AU:T%%*9< MY'#`$&A*G1L`FF;#WNE:UJ66%7O;U&O=#78^J[:ONI;!(PCY=K4@A`E/4A9E M"4\93\%.S(Q:;)!$QZYD$4]S/,4ZDXR4H7-_W2LC\2A(XQ[#F82S0[*09RDK M4A[!(4E1%/F90\*N#>,N,@2&T[%EH"&MIV'N6/P"**RD:7**-.3SJ9`[A3@A M\2'@I]+A\TS$8R9<`;FKE(1$&+51AG4-.S2]@6_M'CBG<*)L,#O"LW]13SGH M:51-5HS&0\O9C7Y2G($NGC18('L(*`,6GJ-$9!76R8>^DH;"74N#K']2+FTQ M%HC)]:-T8;%!/]:@[JII>X#.=%U6_5JM8K8'BZ%T&M\G-9P M9F,?9.A'0VN&"J3>0ESP*PB;#EZZDT>?9AP%1J`2`.G)#P7C7"&AP.9#227H MWLWM.Q;&UY-ZDK#@1?(OVA'_2SM3\"U'1NE, M1)]8:+EF:40`H"H-F9QX9BNAAOOD2:]["/ZVH2M;MFRM#"A@S38&!)CA_8N/ MNN188^<5X0I8V9A]`S)2UN;`9+6^8GUKM;%6G2)L<%E-;D[,=?>IL9S5-=9Z M2#[6/[J4V*8Q[,:TG+U1567U8/$E_`3=I"^2@_?E>P]\;&C/)]6V:.07!7$T M5ZX#HKKK(A?'9^"Y*[)_T#4%[`=A@$N(?8=(ZLY6D)F`K5;)VL\B=X^W/<9: M/7>*-,-DN=,@7X@#%L#0L[/P3.LOX8;W7%[`[4`D%Z'>>S83%)J'.S9N4 M-1RHRIY0-YN-+I4!B;F`YF3YG!HMNV)DZK@LN*".TWO%\->XZ5`A0H]5TB%L9I!^'6W&XHKQ#B;45T,RK?,A)89ZE.K:\@[U+P#]$YP M]6#V>C"S4S5JR8$NT-(1O/24GC\T[-R;YLG'5&C06V_1`!,`,W6?=)MAP2)\ M4)%.`PA3]S!:0ML2#`Z73=W)LF,?'IKJ(-F';2T[8&3\T$( MGA]3^\7M"47!W9[V[A0>]/C0,)0@2.%AKP\)(P)U=IG>*G)+>"Q01M%JY1Z" MLFH?D&2@ZY1I+5-RGL2SRI"==@?`S8EU0.3,GIAX2,!/^AM-*;(%]B_W+>QS MTP*ZG<1@=O"F)I8V&-!^Q2=L-,KV$8,!2QK8]T-;9V*>S,O< M^,XB7"NWHR0V$%HS$8N/92CY624#(=J!B,^4)0_N!JB+JCI@VR-*)D7&P M!&PO^Q*!)9'>58<6YJ,OLKB@1A<&.;VX0DV(A@]#T]/JP:>*P>S''7X@3_C1 M]&?\`#[AIHR/NZ'DV_7J9"$?CAG+U03PFFS!$>V`=!R,]L>9;IB1@^$:MR?3 M@D-X,UC5=I"_<+02A!7!E+T9O;G1$97-C7!E+U1R=654 M>7!E+T9O;G1$97-C7!E+T9O;G0^/@UE;F1O8FH--B`P(&]B:@T\/"]. M=6US6S`@-R`P(%)=/CX-96YD;V)J#3<@,"!O8FH-/#PO4R]$/CX-96YD;V)J M#3@@,"!O8FH-/#PO0V]U;G0@,B]4>7!E+U!A9V5S+TMI9'-;,3,@,"!2(#$@ M,"!273X^#65N9&]B:@TY(#`@;V)J#3P\+U-U8G1Y<&4O6$U,+TQE;F=T:"`S M-C$P+U1Y<&4O365T861A=&$^/G-TFMC.60B/SX*/'@Z>&UP;65T M82!X;6QN#IX;7!T:STB061O8F4@6$U0 M($-O&EO;B!#;VUM96YT($QE='1E&%P+S$N,"\B/@H@("`@("`@("`\>&%P.D-R96%T941A=&4^ M,C`P.2TP,2TR.%0Q-3HP,#HP-RTP-3HP,#PO>&%P.D-R96%T941A=&4^"B`@ M("`@("`@(#QX87`Z0W)E871O&%P34TZ26YS=&%N8V5)1#YU=6ED.C&%P34TZ26YS=&%N8V5)1#X*("`@("`@/"]R9&8Z M1&5S8W)I<'1I;VX^"B`@(#PO -----END PRIVACY-ENHANCED MESSAGE-----